Table 4 Performance of ACS risk score by subgroup risk
ACS risk scoreDiabetes C-index (95% CI)No diabetes C-index (95% CI)Chronic renal failure C-index (95% CI)No chronic renal failure C-index (95% CI)Angina C-index (95% CI)No angina C-index (95% CI)
PURSUIT50.74 (0.72 to 0.76)0.79 (0.79 to 0.81)0.71 (0.67 to 0.75)0.79 (0.78 to 0.80)0.77 (0.75 to 0.78)0.80 (0.79 to 0.82)
GUSTO-160.79 (0.76 to 0.82)0.80 (0.79 to 0.82)0.65 (0.56 to 0.73)0.80 (0.79 to 0.82)0.75 (0.71 to 0.78)0.80 (0.79 to 0.83)
GRACE In-hospital70.77 (0.76 to 0.78)0.81 (0.81 to 0.81)0.71 (0.68 to 0.74)0.80 (0.80 to 0.81)0.78 (0.77 to 0.80)0.82 (0.81 to 0.82)
GRACE 6-months80.76 (0.75 to 0.77)0.81 (0.80 to 0.81)0.69 (0.66 to 0.72)0.79 (0.79 to 0.80)0.76 (0.75 to 0.77)0.81 (0.81 to 0.82)
SRI100.74 (0.73 to 0.76)0.80 (0.79 to 0.81)0.69 (0.64 to 0.74)0.79 (0.79 to 0.80)0.75 (0.73 to 0.77)0.80 (0.79 to 0.81)
EMMACE110.76 (0.74 to 0.78)0.81 (0.80 to 0.81)0.70 (0.64 to 0.75)0.80 (0.79 to 0.81)0.75 (0.74 to 0.77)0.81 (0.80 to 0.82)
  • EMMACE, Evaluation of the Methods and Management of Acute Coronary Events; GRACE, Global Registry of Acute Coronary Events; GUSTO-1, Global Utilisation of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; PURSUIT, Predictors of Outcome in Patients with Acute Coronary Syndromes without Persistent ST Segment Elevation; SRI, SRI, Simple Risk Index.